Palo Alto Networks' (PANW) potential acquisition of CyberArk (CYBR) would complement Palo Alto's existing and bolster its ...

An EU pharma lobby has criticized the Trump administration’s plans to impose 15% tariffs on pharmaceutical imports amid uncertainty over how the newly announced U.S.-EU trade deal targets the product ...

Haverhill contributed €14 million in net sales and €3 million in Core EBITDA in H1 2025 consolidated results, compared to €25 million in net sales and €9 million in Core EBITDA in H1 2024, and €35 ...

Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment ...

CyberArk Software ( NASDAQ: CYBR) soared 13% on a report that Palo Alto Networks ( NASDAQ: PANW) is in discussions to ...

Source: Bloomberg, data from to 31 March 2025 to 30 June 2025. Returns are for the MSCI All Country World Index (ACWI) and its 11 sectors. The MSCI ACWI Index captures large- and mid-cap ...

A new real-world analysis from UK drugmaker Indivior (Nasdaq: INDV) suggests that patients with opioid use disorder (OUD) ...

Sarepta Therapeutics (Nasdaq: SRPT) has been cleared by the American medicines regulator to resume shipments of its gene ...

The US Food & Drug Administration (FDA) has approved Danish biotech Ascendis Pharma’s Skytrofa (lonapegsomatropin-tcgd; ...

US biotech PTC Therapeutics’ shares trading up 4.8% to $46.48 in after-hours activity yesterday, as it announced that the US ...

AstraZeneca PLC ( NASDAQ: AZN) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ET ...

Dr. Mates said: "Medincell is entering a new era and I’m excited to help shape its future. Its vision and achievements closely align with my passion for advancing medical innova ...